• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球假冒抗生素最新动态;公共卫生风险。

Update on counterfeit antibiotics worldwide; public health risks.

机构信息

Laboratoire de Pharmacotechnie Industrielle, Faculté des Sciences Pharmaceutiques et Biologiques, 59006 Lille, France.

出版信息

Med Mal Infect. 2012 Jun;42(6):247-55. doi: 10.1016/j.medmal.2012.04.007. Epub 2012 May 22.

DOI:10.1016/j.medmal.2012.04.007
PMID:22621827
Abstract

Antibiotics are the most counterfeited medicines and account for 28% of global counterfeit medicines. Counterfeit antibiotics are estimated at 5% of the global antibiotic market. No area in the world seems to be spared from counterfeiting of antibiotics. However, these are rare in developed countries, whereas the strong demand for antibiotics in emerging countries creates a highly attractive market for counterfeiters. Thus, 78% of counterfeit antibiotics come from South-East Asia and their destination is mainly emerging countries (South-East Asia: 44%; sub-Saharan Africa: 30%; Europe, North America: 9%; others: 16%). Counterfeit antibiotics are antibiotics that have been commonly used for years (beta-lactams: 50%; quinolones: 12%; macrolides, lincosamides, and synergistins: 1%; cyclins: 7%; others: 20%). The main counterfeit formulations (77%) concern oral administration (tablets, syrup, capsules) whereas injected drugs account for only 17% of counterfeit formulations, and eye drops and ointments 6%. The kind of counterfeiting for antibiotics is similar to that of other drugs (no active ingredients: 43%; bad quality: 24%; insufficient quantity of active ingredients: 21%; wrong active ingredients: 7%; counterfeit packaging: 5%). Beyond the harmful effects for patients, counterfeit medicines favor the emergence of bacterial resistance with a worldwide impact. Great efforts have been made to fight global counterfeiting of medicines since 1985.

摘要

抗生素是最容易造假的药品,占全球假药的 28%。假抗生素估计占全球抗生素市场的 5%。世界上没有哪个地区似乎能幸免于抗生素造假。然而,在发达国家这种情况很少见,而新兴国家对抗生素的强劲需求为造假者创造了一个极具吸引力的市场。因此,78%的假冒抗生素来自东南亚,其目的地主要是新兴国家(东南亚:44%;撒哈拉以南非洲:30%;欧洲、北美:9%;其他地区:16%)。假冒抗生素是多年来常用的抗生素(β-内酰胺类:50%;喹诺酮类:12%;大环内酯类、林可酰胺类和链阳性菌素类:1%;环素类:7%;其他:20%)。主要的假冒制剂(77%)涉及口服(片剂、糖浆、胶囊),而注射药物仅占假冒制剂的 17%,滴眼剂和软膏占 6%。抗生素的造假方式与其他药物类似(无有效成分:43%;质量差:24%;有效成分含量不足:21%;有效成分错误:7%;假冒包装:5%)。除了对患者造成的有害影响外,假药还助长了细菌耐药性的出现,产生了全球性的影响。自 1985 年以来,人们为打击全球假药已做出了巨大努力。

相似文献

1
Update on counterfeit antibiotics worldwide; public health risks.全球假冒抗生素最新动态;公共卫生风险。
Med Mal Infect. 2012 Jun;42(6):247-55. doi: 10.1016/j.medmal.2012.04.007. Epub 2012 May 22.
2
[Counterfeit medicines: a growing threat].[假药:日益严重的威胁]
Med Trop (Mars). 2006 Dec;66(6):529-32.
3
An LC method for the simultaneous screening of some common counterfeit and sub-standard antibiotics Validation and uncertainty estimation.一种用于同时筛查某些常见假冒和不合格抗生素的液相色谱法:验证与不确定度评估
J Pharm Biomed Anal. 2008 Sep 29;48(2):303-9. doi: 10.1016/j.jpba.2007.12.032. Epub 2007 Dec 26.
4
Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.不合格及假冒抗菌药物:发展中国家的近期趋势及其对关键公共卫生干预措施的影响
East Afr J Public Health. 2012 Jun;9(2):85-9.
5
[Counterfeit phosphodiesterase type 5 inhibitors--growing safety risks for public health].[假冒的5型磷酸二酯酶抑制剂——对公众健康的安全风险与日俱增]
Rocz Panstw Zakl Hig. 2010;61(3):227-35.
6
Poor-Quality and Counterfeit Drugs: A Systematic Assessment of Prevalence and Risks Based on Data Published From 2007 to 2016.劣质和假冒药品:基于 2007 年至 2016 年发表的数据进行的流行率和风险的系统评估。
J Pharm Sci. 2017 Oct;106(10):2921-2929. doi: 10.1016/j.xphs.2017.05.018. Epub 2017 May 23.
7
Development and validation of a reversed-phase LC method for analysing potentially counterfeit antimalarial medicines.一种用于分析潜在假冒抗疟药物的反相液相色谱法的开发与验证
J Pharm Biomed Anal. 2006 Sep 11;42(1):132-5. doi: 10.1016/j.jpba.2006.01.059. Epub 2006 Mar 6.
8
[The fight against counterfeit medicines in Africa: experience and role of pharmacists].[非洲打击假药的斗争:药剂师的经验与作用]
C R Biol. 2008 Dec;331(12):982-5. doi: 10.1016/j.crvi.2008.08.017. Epub 2008 Oct 21.
9
[Update on counterfeit drugs: a growing risk for public health].[假药最新情况:对公众健康构成日益严重的风险]
Bull Acad Natl Med. 2008 Oct;192(7):1423-34; discussion 1434-6.
10
Counterfeit drugs and medical devices in developing countries.发展中国家的假冒药品和医疗器械。
Res Rep Trop Med. 2014 Apr 24;5:11-22. doi: 10.2147/RRTM.S39354. eCollection 2014.

引用本文的文献

1
Mitigating inequitable access to appropriate antibiotics in low- and middle-income countries.缓解低收入和中等收入国家在获取适当抗生素方面的不平等现象。
JAC Antimicrob Resist. 2025 Apr 24;7(2):dlaf061. doi: 10.1093/jacamr/dlaf061. eCollection 2025 Apr.
2
Antimicrobial resistance related knowledge, attitude and practice of general practitioners, patients and farmers: A cross-sectional study in Uzbekistan.乌兹别克斯坦全科医生、患者和农民的抗菌药物耐药性相关知识、态度和行为:一项横断面研究
Heliyon. 2024 Sep 8;10(19):e37566. doi: 10.1016/j.heliyon.2024.e37566. eCollection 2024 Oct 15.
3
Quality improvement in medicines regulation: a retrospective analysis of the Pharmacy Board of Sierra Leone before and during quality management system implementation.
药品监管质量改进:塞拉利昂药剂师管理局在实施质量管理体系之前和期间的回顾性分析。
BMC Health Serv Res. 2024 Sep 3;24(1):1020. doi: 10.1186/s12913-024-11452-8.
4
The importance of "one health approach" to the AMR study and surveillance in Angola and other African countries.“同一健康方法”对安哥拉及其他非洲国家抗菌药物耐药性研究与监测的重要性。
One Health. 2024 Feb 1;18:100691. doi: 10.1016/j.onehlt.2024.100691. eCollection 2024 Jun.
5
Evaluating the Potency of Selected Antibiotic Medications Dispensed in Community Pharmacies in Gwale, Kano, Nigeria.评估尼日利亚卡诺州瓜莱社区药房所售部分抗生素药物的效力。
Antibiotics (Basel). 2023 Oct 31;12(11):1582. doi: 10.3390/antibiotics12111582.
6
Tackling Counterfeit Drugs: The Challenges and Possibilities.打击假药:挑战与可能性。
Pharmaceut Med. 2023 Jul;37(4):281-290. doi: 10.1007/s40290-023-00468-w. Epub 2023 May 15.
7
In vitro Efficacy Evaluation of Leading Brands of Ciprofloxacin Tablets Found in Bishoftu City Against Isolates, Central Ethiopia.埃塞俄比亚中部比绍夫图市发现的环丙沙星片主要品牌对分离株的体外疗效评估
Infect Drug Resist. 2023 Mar 14;16:1433-1440. doi: 10.2147/IDR.S402640. eCollection 2023.
8
Challenges Associated with Addressing Counterfeit Medicines in Nigeria: An Exploration of Pharmacists' Knowledge, Practices, and Perceptions.尼日利亚应对假药问题的挑战:药剂师的知识、实践与认知探索
Integr Pharm Res Pract. 2022 Dec 16;11:177-186. doi: 10.2147/IPRP.S387354. eCollection 2022.
9
Assessment of the Quality of Injectable Antibiotics in Benin.贝宁注射用抗生素质量评估。
Am J Trop Med Hyg. 2022 Jun 6;107(1):24-31. doi: 10.4269/ajtmh.21-0844. Print 2022 Jul 13.
10
Unpacking multi-level governance of antimicrobial resistance policies: the case of Guangdong, China.解析抗微生物药物耐药性政策的多层次治理:以中国广东为例。
Health Policy Plan. 2022 Oct 12;37(9):1148-1157. doi: 10.1093/heapol/czac052.